Search results
Lupus Complications Reduced With Common Diabetes Drug
MedPage Today· 2 days agoPeople with systemic lupus erythematosus (SLE) had lower rates of lupus nephritis, chronic kidney disease, and other complications when ...
CAR-T therapy achieves lupus remission breakthrough
BioPharma-Reporter· 4 days agoThis is the first trial to date to show safe elimination of all autoantibodies in patients with systemic lupus erythematosus (SLE) and lupus nephritis...
Kyverna's CAR-T relapse in lupus dents autoimmune hopes amid biotech gold rush
FierceBiotech· 5 days agoThe “remarkable” success of chimeric antigen receptor T-cell therapy (CAR-T) in lupus has led to a...
US FDA approves Roche's drug for a chronic blood disorder
Reuters via AOL· 17 hours agoThe drug crovalimab, branded as PiaSky, is a monthly under-the-skin or intravenous treatment for...
Strength Seen in Aurinia (AUPH): Can Its 5.6% Jump Turn into More Strength?
Zacks via Yahoo Finance· 5 days agoAurinia (AUPH) saw its shares surge in the last session with trading volume being higher than...
Multiscale topology classifies cells in subcellular spatial transcriptomics - Nature
Nature· 3 days agoA method for topological automatic cell type classification across subcellular resolution spatial transcriptomic platforms is proposed, resolving cell type information and locating sparsely dispersed cells in human kidney and mouse kidney and brain.
First-in-Disease Use of Kyverna Therapeutics' KYV-101 in Patient With Severe Stiff-Person Syndrome...
Lodi News-Sentinel· 5 days ago"It is extremely encouraging to see this patient improving the self-reported, uninterrupted walking distance from less than 50...
Sierra Summit Advisors LLC Acquires New Shares in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
ETF DAILY NEWS· 6 days agoSierra Summit Advisors LLC acquired a new stake in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) during the fourth quarter, Holdings Channel reports. The fund acquired 22,436 ...
Q32 Bio (NASDAQ:QTTB) Receives New Coverage from Analysts at Guggenheim
ETF DAILY NEWS· 4 days agoGuggenheim assumed coverage on shares of Q32 Bio (NASDAQ:QTTB – Free Report) in a research report released on Monday, Marketbeat reports. The firm issued a buy rating and a $100.00 target price ...
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Up 3.9%
ETF DAILY NEWS· 6 days agoAurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Free Report) (TSE:AUP) rose 3.9% on Friday . The stock traded as high as $5.60 and last traded at $5.56. Approximately 1,389,155 shares traded ...